Such CD39-T immunoregulatory cell populations in the GALT have also been described in mouse EAE after the repopulation that followed a treatment with anti-CD52 antibody, which is also a very potent immunosuppressive treatment for MS (36). The gene discussed is CD52; the disease is myeloid sarcoma.